Investment
Features
FeesSafety
Academy
More
Pluang+

Compare General Dynamics Corporation (GD) vs Hims and Hers Health Inc (HIMS) Price & Performance

General Dynamics CorporationTrade
Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

General Dynamics Corporation vs Hims and Hers Health Inc — how do they compare? General Dynamics Corporation trades at $391.11 (market cap $107.13B), while Hims and Hers Health Inc trades at $30.71 (market cap $7.35B). The key difference: General Dynamics Corporation is far larger — about 14.6× Hims and Hers Health Inc's market cap, and General Dynamics Corporation pays a 1.61% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.

GDHIMS
Market Cap
$107.13B$7.35B
Sector
IndustrialsHealth
52-Week High
$395.97$62.76
52-Week Low
$312.53$14.52
Enterprise Value
$112.28B$7.73B
Dividend Yield
1.61%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

General Dynamics Corporation

General Dynamics (GD) trades at $392.05, up 1.33% today, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $4.24 versus $3.96 expected, with revenue growth across all segments. A $76.6 billion Navy contract awarded in July 2026 bolsters its backlog to $136.5 billion, providing visibility for future growth.

The stock offers upside to the $427.40 consensus price target, driven by defense spending tailwinds and operational execution. Risks include valuation at a 23.91 P/E and potential contract execution delays. Analyst sentiment is positive with 57% buy ratings, but overbought RSI levels near-term may limit gains.

Hims and Hers Health Inc

Hims & Hers Health stock trades at $31.59, up 6.51% today, showing strong momentum. The technical outlook is bullish, with the price above key moving averages and support at $30. Fundamentally, revenue growth is robust at 40% year-over-year in Q2 2026 (MarketBeat, 2026-08-10), but profitability remains challenged with a net loss margin of -0.56% in 2026. The company raised its annual revenue forecast to $3.1–3.3 billion (WSJ, 2026-08-10), reflecting confidence in subscriber growth and expansion into weight-loss treatments.

The investment outlook is mixed: strong revenue growth and bullish analyst targets near $35.60 offer upside, but high valuation ratios (P/E of 57.14) and recent earnings misses heighten risk. Key risks include margin pressure from GLP-1 investments and ongoing legal investigations. Wall Street sentiment is cautious, with 65% hold ratings, suggesting patience for profitability improvements.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About General Dynamics Corporation

General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.

Read more on GD

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS